A

Alexion

Global biopharmaceuticals focusing on rare diseases

Head of Sterility Assurance and Contamination Control

Regulatory & Quality (Life Sciences)Posted on Nov 10
Full-timeDublin, IrelandNo salary listedIn-person

About the Job

Requirements

  • A bachelor's degree in microbiology, biology, or a related life science is required.
  • At least 15 years of experience in sterility assurance, aseptic processing, contamination control, or industrial microbiology in biopharma within a GMP quality or technical operations environment is required.
  • Prior leadership of an SA&CC function or equivalent at comparable scale is required, including demonstrated ability to direct, mentor, and develop teams.
  • Deep expertise in evolving global aseptic processing and sterile drug regulatory expectations is required, including a track record of authoring and defending contamination control strategies and acting as a subject matter expert in health authority inspections.
  • Deep knowledge of aseptic processing, cleanroom classification, HVAC principles, sterilisation technologies, environmental monitoring, aseptic process simulation, and quality risk management is required.
  • Experience with combination product aseptic processing and container-closure integrity is required.
  • Broad expertise in microbiological methods used in sterile manufacturing, including method validation, is required.
  • Experience leading sterility failure and contamination investigations is required, including root cause analysis, product impact assessment, and CAPA effectiveness.
  • Strong working knowledge of GMP and the Pharmaceutical Quality System is required, including deviation, CAPA, change control, quality risk management, data integrity, quality metrics, and management review.
  • Strong influencing skills at the boundary between Quality and Technical Operations are required, including bridging science and operations through matrixed influence in a global governance and standards-setting role.
  • Demonstrated experience establishing or governing sterility assurance standards across multiple sites and/or external manufacturing partners is required.
  • Experience leading sterility assurance and contamination control for facility design, qualification, and start-up of aseptic operations is required.

Responsibilities

  • Set and own the global sterility assurance and contamination control strategy, harmonized standards, and technical positions; ensure consistent application and measurable outcomes across the network.
  • Define the technical content and structure for integrated, science- and risk-based contamination control strategy documents; jointly review and approve site strategies with Quality Assurance, keep them current and compliant, and verify their effectiveness through periodic reviews.
  • Establish network standards for aseptic design and operation, including cleaning and disinfection, sporicidal programs, cleanroom design and qualification, environmental monitoring programs, gowning and personnel qualification, material and equipment transfer, and sterilization validation; provide input on HVAC, utilities, and facility design.
  • Own the global aseptic process simulation strategy and technical standards to ensure simulations provide robust proof of control and continued aseptic capability.
  • Coordinate responses to contamination and sterility assurance events; lead complex investigations and root cause analysis; define effective corrective and preventive actions; assess product impact to support Quality Assurance batch disposition; and escalate significant issues through quality governance.
  • Apply International Council for Harmonisation Q9 tools, such as failure mode and effects analysis and contamination risk mapping; trend environmental monitoring, deviation, and investigation data to identify emerging risks; define sterility assurance and contamination control metrics and key performance indicators for management review; own related procedures within document control; provide assessments for change control; assure data integrity and GMP compliance of environmental monitoring and microbiological data; and support self-inspections.
  • Monitor and interpret evolving global expectations for aseptic processing; act as lead technical subject matter expert in inspections, audits, and health authority interactions; ensure timely closure of observations; and contribute sterility assurance and contamination control content for submissions and responses with Regulatory Affairs.
  • Serve as a standing member of new product introduction and technology transfer steering; embed contamination control by design in new products and facilities; and align on risk assessments and validation expectations before transfer, qualification, and release.
  • Set strategy and standards for microbiological methods; introduce rapid microbial methods, barrier and isolator technologies, automation, and advanced analytics for contamination-signal detection and environmental monitoring trending under robust validation, change control, data integrity, and human-oversight frameworks.
  • Mentor and coach site microbiology and aseptic teams; build a talent pipeline in scarce aseptic expertise; upskill cross-functional teams in microbiological risk and aseptic behaviors; and cultivate a culture of prevention, accountability, and continuous improvement.

Desired Qualifications

  • A master's degree or PhD in microbiology or a related life science is preferred.
  • Experience in Quality Assurance or Quality Control roles, or in contract development and manufacturing organization quality oversight, is preferred.
  • Understanding of artificial intelligence and advanced analytics applied to environmental monitoring and microbial data, and awareness of the emerging regulatory landscape for artificial intelligence and machine learning in microbial control, is preferred.

About the Company

Alexion

Global biopharmaceuticals focusing on rare diseases

Alexion, now the rare disease group within AstraZeneca, develops and sells therapies for rare and ultra-rare diseases by targeting the complement immune system. Its drugs, such as Soliris and Ultomiris, inhibit the C5 component to slow or stop disease processes, while Strensiq and Kanuma address specific metabolic disorders. It differentiates itself through a deep focus on complement biology, pursuing first- or best-in-class therapies, and using a strategy that blends internal R&D with acquisitions to expand its pipeline. Its goal is to improve outcomes for patients with rare diseases and bring these therapies to a broader international market using AstraZeneca’s scale and capabilities.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Boston, MA
Founded
1992

Recently Posted Jobs

Explore more opportunities at Alexion

See more jobs